IFNA1 and neurodegenerative disease: Activation of STING signaling is linked to other neurodegenerative diseases, and inhibiting STING activation protects against deleterious effects of IFN responses in Parkinson’s disease, Huntington’s disease and amyotrophic lateral sclerosis11–13.